Stem Cell Therapy Market: By Cell Source (Adipose tissue-derived MSCs (mesenchymal stem cells), Bone marrow-derived MSCs, Placental and umbilical cord-derived MSCs, Other Cell Sources); Type (Autologous stem cell therapy and Allogeneic Stem Cell Therapy); Delivery Method (In Vivo and Ex Vivo); Therapeutic Use (Oncology, Musculoskeletal disorders, Wounds and injuries, Cardiovascular, System diseases, Surgery, Inflammatory and autoimmune diseases, Nervous system disorders, Drug Discovery, Others); End Users (Hospitals, Ambulatory Surgical Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others); Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025–2033
Stem cell therapy market was valued at US$ 394.50 million in 2024 and is projected to hit the market valuation of US$ 2,612.92 million by 2033 at a CAGR of 23.97% during the forecast period 2025–2033. Read More
We Are Trusted By These Great Companies!
Published On: 04-Dec-2024 | Format: | Report ID: AA1224993